Results of the phase 3 STRENGTH study show that intrathecal onasemnogene abeparvovec has a favorable safety profile consistent with findings in treatment-naïve patients and may be another treatment ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The holidays are almost here and, if you ask us, that's the best time of year to settle down and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback